URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

Scott Ullem Biography and Net Worth

CFO of Edwards Lifesciences

Scott B. Ullem has been corporate vice president, chief financial officer since January 2014. In addition, Ullem has executive responsibility for the company’s information technology, information security, risk management, indirect sourcing, and corporate services teams. Prior to joining Edwards, he served as chief financial officer of Bemis Company Inc., a Fortune 500 publicly traded global supplier of packaging and pressure sensitive materials used in leading food, consumer, and healthcare products, from May 2010 to December 2013. Ullem also had leadership responsibility for one of Bemis' three business segments and the company's information technology function. Prior to Bemis, Ullem spent 17 years in investment banking, serving as managing director at Goldman Sachs and later at Bank of America. He has served on the board and compensation committee of Berry Global, Inc., since 2016, and is a Henry Crown Fellow at the Aspen Institute. He is a passionate supporter of healthcare initiatives aimed at improving hospital quality and safety. In 2014, he joined the board of the Edwards Lifesciences Foundation. Ullem received his bachelor's degree in political science from DePauw University and his master's degree in business administration from Harvard Business School.

What is Scott B. Ullem's net worth?: The estimated net worth of Scott B. Ullem is at least $2.25 million as of May 21st, 2024. Mr. Ullem owns 30,561 shares of Edwards Lifesciences stock worth more than $2,246,845 as of December 23rd. This net worth estimate does not reflect any other investments that Mr. Ullem may own. Additionally, Mr. Ullem receives a salary of $1,350,000.00 as CFO at Edwards Lifesciences. Learn More about Scott B. Ullem's net worth.
How old is Scott B. Ullem?: Mr. Ullem is currently 57 years old. There are 6 older executives and no younger executives at Edwards Lifesciences. The oldest executive at Edwards Lifesciences is Mr. Arnold A. Pinkston, Corporate VP & General Counsel, who is 65 years old. Learn More on Scott B. Ullem's age.
What is Scott B. Ullem's salary?: As the CFO of Edwards Lifesciences Co., Mr. Ullem earns $1,350,000.00 per year. There are 2 executives that earn more than Mr. Ullem. The highest earning executive at Edwards Lifesciences is Mr. Bernard J. Zovighian, CEO & Director, who commands a salary of $2,270,000.00 per year. Learn More on Scott B. Ullem's salary.
How do I contact Scott B. Ullem?: The corporate mailing address for Mr. Ullem and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Scott B. Ullem's contact information.
Has Scott B. Ullem been buying or selling shares of Edwards Lifesciences?: Scott B. Ullem has not been actively trading shares of Edwards Lifesciences during the last quarter. Most recently, Scott B. Ullem sold 5,625 shares of the business's stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $90.45, for a transaction totalling $508,781.25. Following the completion of the sale, the chief financial officer now directly owns 30,561 shares of the company's stock, valued at $2,764,242.45. Learn More on Scott B. Ullem's trading history.
Who are Edwards Lifesciences' active insiders?: Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Daniel Lippis (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.
Are insiders buying or selling shares of Edwards Lifesciences?: In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 580 shares worth more than $49,729.20. In the last year, insiders at the medical research company sold shares 34 times. They sold a total of 377,713 shares worth more than $31,439,247.64. The most recent insider tranaction occured on December, 16th when VP Daniel J Lippis sold 2,500 shares worth more than $185,200.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.
Information on this page was last updated on 12/16/2024.

Scott B. Ullem Insider Trading History at Edwards Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/21/2024	Sell	5,625	$90.45	$508,781.25	30,561
4/30/2024	Sell	7,250	$85.80	$622,050.00	19,074
4/1/2024	Sell	7,255	$94.89	$688,426.95	19,074
2/29/2024	Sell	7,255	$85.59	$620,955.45	19,074
2/1/2024	Sell	7,255	$78.29	$567,993.95	19,248
12/29/2023	Sell	14,510	$76.55	$1,110,740.50	19,248
10/31/2023	Sell	7,255	$62.66	$454,598.30	19,248
9/29/2023	Sell	7,255	$69.54	$504,512.70	19,248
8/31/2023	Sell	7,255	$77.79	$564,366.45	19,248
7/31/2023	Sell	7,255	$84.35	$611,959.25	19,248
6/30/2023	Sell	7,255	$93.27	$676,673.85	19,248
5/10/2023	Sell	80,700	$88.54	$7,145,178.00	18,294
10/26/2020	Sell	33,150	$78.81	$2,612,551.50	60,264
10/12/2020	Sell	33,150	$83.81	$2,778,301.50	60,264
9/28/2020	Sell	33,150	$78.11	$2,589,346.50	60,264
9/14/2020	Sell	26,700	$82.21	$2,195,007.00	53,814
8/6/2020	Sell	26,700	$77.31	$2,064,177.00	53,814
7/6/2020	Sell	26,700	$69.98	$1,868,466.00	53,814
6/22/2020	Sell	26,700	$69.51	$1,855,917.00	27,114
1/7/2020	Sell	7,500	$234.25	$1,756,875.00	17,438
12/10/2019	Sell	7,500	$233.88	$1,754,100.00	17,438
11/12/2019	Sell	7,500	$234.28	$1,757,100.00	17,438
10/29/2019	Sell	7,500	$235.30	$1,764,750.00	9,938
9/9/2019	Sell	7,500	$225.74	$1,693,050.00	21,064
8/26/2019	Sell	7,500	$213.44	$1,600,800.00	21,064
9/5/2018	Sell	25,036	$140.04	$3,506,041.44	41,019
7/3/2018	Sell	25,000	$145.67	$3,641,750.00	41,265
6/6/2018	Sell	25,000	$141.07	$3,526,750.00	41,265
5/9/2018	Sell	25,000	$134.73	$3,368,250.00	35,968
4/4/2018	Sell	25,000	$137.17	$3,429,250.00	35,968
3/28/2018	Sell	25,000	$137.33	$3,433,250.00	35,968

Scott B. Ullem Buying and Selling Activity at Edwards Lifesciences

Edwards Lifesciences Company Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Today's Range

Now: $73.52

$73.45

$74.90

50 Day Range

MA: $70.06

$65.75

$74.81

2 Week Range

Now: $73.52

$58.93

$96.12

Volume

750,248 shs

Average Volume

4,709,301 shs

Market Capitalization

$43.36 billion

P/E Ratio

10.61

Dividend Yield

N/A

Beta

1.12

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

>> Register for the Workshop Now

Scott Ullem Biography and Net Worth

What is Scott B. Ullem's net worth?

How old is Scott B. Ullem?

What is Scott B. Ullem's salary?

How do I contact Scott B. Ullem?

Has Scott B. Ullem been buying or selling shares of Edwards Lifesciences?

Who are Edwards Lifesciences' active insiders?

Are insiders buying or selling shares of Edwards Lifesciences?